## CRM: Salesforce, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.13 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($220.99)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Salesforce, Snowflake, Dollar Tree, and more set to report earnings Wednesday**
- Source: Investing.com | 20251202T140000 | Neutral | Relevance: 100%
- Salesforce, Snowflake, and Dollar Tree are among the key companies scheduled to report earnings on Wednesday, providing investors with insight into various sectors. The article lists estimated EPS and revenue for these and several other companies reporting before and after market close. Investors are encouraged to use Investing.com's earnings calendar for real-time updates and an InvestingPro subscription for in-depth metrics.

**2. Salesforce Inc. $CRM Shares Sold by Panagora Asset Management Inc.**
- Source: MarketBeat | 20251201T122925 | Neutral | Relevance: 99%
- Panagora Asset Management Inc. significantly reduced its stake in Salesforce Inc. ($CRM) by 61.6% in the second quarter. Despite this, several other institutional investors, including Vanguard Group Inc. and Geode Capital Management LLC, increased their holdings in the company. The article also provides recent analyst ratings, stock performance metrics, and details on Salesforce's latest earnings and dividend announcements.

**3. Arrowstreet Capital Limited Partnership Grows Stock Holdings in Salesforce Inc. $CRM**
- Source: MarketBeat | 20251202T083210 | Somewhat-Bullish | Relevance: 99%
- Arrowstreet Capital Limited Partnership significantly increased its stake in Salesforce Inc. during the second quarter of 2025, acquiring an additional 894,469 shares and now owning 0.26% of the company. Other institutional investors also adjusted their positions, with several boosting their holdings. The article details Salesforce's recent financial performance, including its Q3 earnings beat and FY 2026 guidance, along with analyst ratings and recent insider transactions.

**4. Citizens Reiterates Salesforce (CRM) Market Outperform Recommendation**
- Source: Nasdaq | 20251202T195600 | Bullish | Relevance: 99%
- Citizens has reiterated a Market Outperform recommendation for Salesforce (CRM), with an average one-year price target of $336.05, suggesting a 44.33% upside from its latest closing price. The article also details fund sentiment, showing a decrease in owners but an increase in average portfolio weight dedicated to CRM among institutional investors. Key institutional holders like Vanguard and Geode Capital Management have significant stakes in the company, with some increasing and others decreasing their allocations.

**5. Stock Market Today: Nasdaq, S&P 500 Futures Down Despite Strong Black Friday Sales â€” Nvidia, MongoDB, Crowdstrike And Salesforce In Focus**
- Source: MSN | 20251201T142121 | Neutral | Relevance: 99%
- Early Monday, U.S. stock futures for the Nasdaq 100 and S&P 500 were trading lower despite strong Black Friday and Cyber Monday sales data. Investors are looking ahead to key economic data this week, including revisions to third-quarter GDP, PCE inflation, and the November jobs report, which could influence the Federal Reserve's monetary policy decisions. Major tech and software companies like Nvidia, MongoDB, Crowdstrike, and Salesforce are in focus due to earnings reports and analyst activity.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 10)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Morgan Stanley | $398 | $405 | -2% |
| 2025-12-08 | Citigroup | $257 | $253 | +2% |
| 2025-12-05 | DA Davidson | $235 | $225 | +4% |
| 2025-12-04 | Truist Securiti | $380 | $400 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Morgan Stanley | main | Overweight |
| 2025-12-08 | Citigroup | main | Neutral |
| 2025-12-05 | DA Davidson | main | Neutral |
| 2025-12-04 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 29 ($26.85M) |
| Sells | 30 ($1.57M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.8%)
- Blackrock Inc.: 8.7% (-0.5%)
- State Street Corpora: 5.3% (+0.3%)
- JPMORGAN CHASE & CO: 2.8% (+46.5%)
- Geode Capital Manage: 2.2% (+0.6%)

### Key Risks

1. Long-term trend broken: trading 9.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 6 raises (avg +4%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.13 suggests fair value with growth premium. Quality metrics strong (margin 18%). Balance sheet: $2.2B free cash flow. Analyst sentiment negative (10 target cuts vs 6 raises). Insider buying signal ($26.9M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $251.5B |
| Beta | 1.25 |
| 52W Range | $221.96 - $367.09 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.13 |
| Forward P/E | 18.0 |
| Current P/E | 20.0 |
| YoY Growth | 10.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -2.7% (minimal 5-day change). Below STRENGTH zone by 6.7pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.5%) - potential reversal signal. Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.66% (CS: 28) | Weak |
| RSI_14 | 46.3 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 0.990x | Below |
| vs SMA50 | 0.965x | Below |
| vs SMA200 | 0.901x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $234.71
- **Stop Loss:** $220.99 (5.8% risk)
- **Target:** $262.15 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 87
- **Position Value:** $20,419.77
- **Portfolio %:** 20.42%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-25 (Est: $3.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.86 | $3.25 | +13.6% |
| 2025Q3 | $2.78 | $2.91 | +4.7% |
| 2025Q2 | $2.55 | $2.58 | +1.3% |
| 2025Q1 | $2.61 | $2.78 | +6.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*